TO Study The Effect Between Two drug Hyperbaric Ropivacaine 0.75% and Hyperbaric Levobupivacaine 0.5% in patient with lower limb Orthopedic Surgeries in Spinal Anasthesia.

A Comparative Study Between Hyperbaric Ropivacaine 0.75% And Hyperbaric Levobupivacaine 0.5% For Elective Lower Limb Orthopedic Surgeries Under Spinal Anasthesia - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/059168

Enrollment

Registered

2023-10-26

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: nil: nil Control Intervention1: HYPERBARIC ROPIVACAINE 0.75% AND HYPERBARIC LEVOBUPIVACAINE 0.5% FOR ELECTIVE LOWER LIMB ORTHOPEDIC SURGERIES UNDER SPINAL ANAESTHESIA: A COMPARATIVE STU

Eligibility

Inclusion criteria

Inclusion criteria: .American Society Of Anasthesiology Physical Status Grade I And II. .Age Between 18-65 Years. .Posted For Lower Limb Orthopedic Surgeries. .Duration Between 60-180 Min.

Exclusion criteria

Exclusion criteria: .Patient Refusal. .Containdication To Regional Anasthesia. .Coagulation Abnormalities. .Known Senstivity of Drug. .History Of Any Drug Abuse.

Design outcomes

Primary

Measure	Time frame
onset and Duration of two drug hyperbaric levobupicaine 0.5% and hyperbaric ropivacaine 0.75%Timepoint: Baseline	—

Secondary

Measure	Time frame
hemodynamic changes any adverse effect patient satisfaction scoreTimepoint: Baseline	—

Countries

India

Contacts

Public ContactDr Dheer singh

Uttar Pradesh University Of Medical Sciences Saifai etawah

SKYDHEER@GMAIL.COM9411259674

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026